About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials Prostate CancerIllinois

Prostate Cancer Clinical Trials in Illinois

Find 545 clinical trials for prostate cancer near Illinois. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 381-400 of 545 trials

CompletedCyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate CancerThe primary objective of this study is to document the effectiveness of Cyberknife stereotactic body radiotherapy (SBRT) in the treatment of intermediate and high-risk localized…NCT01985828·Park Ridge, Illinois CompletedSafety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based ChemotherapyThis is a phase 3 study to compare the clinical benefit of MDV3100 versus placebo in patients with castration-resistant prostate cancer who have been previously treated with…NCT00974311·Birmingham, Alabama and 248 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedAdenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate CancerThis is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of etrumadenant (AB928)-based combination therapy in participants with…NCT04381832·Cerritos, California and 18 others

RecruitingStudy Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCThe purpose of this study is to determine whether \[225Ac\]Ac-PSMA-617 (AAA817), given for up to 6 cycles at a dose of 10 Megabecquerel (MBq) +/- 10%, plus androgen receptor…NCT06855277·Homewood, Alabama and 105 others

TerminatedAndrogen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone MetastasesNewly diagnosed metastatic prostate cancer subjects with bone metastases will be accrued to this stratified randomized 2-arm Phase II trial.NCT02582749·Phoenix, Arizona and 11 others

CompletedDose Escalation and Efficacy Trial of GVAX® Prostate Cancer VaccineThe purpose of this study is to evaluate clinical and laboratory safety in patients receiving 4 different doses of GVAX® Prostate Cancer Vaccine in order to determine a maximum…NCT00140348·Laguna Woods, California and 11 others

Active not recruitingWater Vapor Ablation for Localized Intermediate Risk Prostate CancerThe purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2)…NCT05683691·Phoenix, Arizona and 24 others

TerminatedEfficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate CancerThe purpose of this study is to evaluate the clinical benefit of the co-administration of propranolol and etodolac (VT-122 therapy) in patients with clinically progressive…NCT01857817·Fayetteville, Arkansas and 15 others

Active not recruitingTesting the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyThis phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with…NCT05053152·Phoenix, Arizona and 244 others

Active not recruitingVeterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate CancerThis is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed local therapy in…NCT04787744·Long Beach, California and 19 others

CompletedA Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate CancerThis is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.NCT03009981·Phoenix, Arizona and 68 others

Active not recruitingAn Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to compare the radiographic progression-free survival (rPFS) of apalutamide in combination with abiraterone acetate (AA) plus prednisone or…NCT02257736·Phoenix, Arizona and 172 others

CompletedS0000 Selenium and Vitamin E in Preventing Prostate CancerRATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer.NCT00006392·Chicago, Illinois and 12 others

Active not recruitingA Study to Test Radium-223 With Docetaxel in Patients With Prostate CancerThe purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone.NCT03574571·Gilbert, Arizona and 71 others

WithdrawnStudy of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.The purpose of this clinical research study is to assess the safety and efficacy of an investigational therapy called DCVax(TM)-Prostate.NCT00043212·Springdale, Arkansas and 15 others

TerminatedPazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen BlockadeA growing body of literature supports the role of angiogenesis in the development and spread of a variety of human cancers including prostate cancer.NCT00945477·Bloomington, Illinois and 3 others

CompletedCYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate CancerThis randomized phase II trial studies how well glycosylated recombinant human interleukin-7 (CYT107) after vaccine therapy works in treating patients with castration-resistant…NCT01881867·La Jolla, California and 15 others

CompletedA Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer PatientsThe purpose of the study is to compare the response rates for prostate cancer patients taking chemotherapy plus enzastaurin versus chemotherapy plus placebo.NCT00466440·Fullerton, California and 27 others

RecruitingStudy to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly PatientsThis study seeks to identify if it is feasible to stop Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Therapy in elderly men with prostate cancer.NCT06824818·Chicago, Illinois and 1 other

TerminatedExpanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)The SPERA trial is designed to 1. provide satraplatin to physicians with patients who have hormone refractory prostate cancer (HRPC) which has progressed following unlimited…NCT00450970·Birmingham, Alabama and 120 others

PreviousPage 20 of 28Next

Other Conditions in Illinois

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma